We conducted a second nationwide severe acute respiratory syndrome coronavirus 2 seroprevalence study in the Faroe Islands during November 2020. We found crude seroprevalence was 0.3% and prevalence was 0.4% after adjusting for test sensitivity and specificity. This low seroprevalence supports the prevention strategies used in the Faroe Islands.
Original languageEnglish
JournalEmerging Infectious Diseases
Issue number1
Publication statusPublished - Nov 2021


  • COVID-19
  • Faroe Islands
  • SARS
  • SARS-CoV-2
  • coronavirus
  • coronavirus disease
  • respiratory infections
  • seroprevalence
  • severe acute respiratory syndrome coronavirus 2
  • viruses
  • zoonoses


Dive into the research topics of 'Low Seroprevalence among Undetected COVID-19 Cases: Faroe Islands, November 2020'. Together they form a unique fingerprint.

Cite this